| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/21/2013 | US8445694 Hydrazonopyrazole derivatives and their use as therapeutics |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8444964 Compositions and methods for enhanced tumor cell immunity in vivo |
| 05/21/2013 | CA2707766C Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
| 05/21/2013 | CA2559802C Method for stimulating the immune, inflammatory or neuroprotective response |
| 05/21/2013 | CA2478011C Bispecific antibody point mutations for enhancing rate of clearance |
| 05/21/2013 | CA2477675C Immunizing composition and method for inducing an immune response against the .beta.-secretase cleavage site of amyloid precursor protein |
| 05/21/2013 | CA2436666C Use of zwitterionic polysaccharides for the specific modulation of immune processes |
| 05/21/2013 | CA2401638C Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2349203C Dispersible phospholipid stabilized microparticles |
| 05/16/2013 | WO2013069765A1 Nitrogenated heterocyclic compound |
| 05/16/2013 | WO2013069611A1 Rna having immunomodulating activity |
| 05/16/2013 | WO2013068847A2 Compositions and methods for treatment of cytomegalovirus |
| 05/16/2013 | WO2013068458A1 Therapeutically active thiazolo-pyrimidine derivatives |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | WO2013067597A1 Immunomodulatory conjugates |
| 05/16/2013 | WO2013033400A9 Methods for effectively and rapidly desensitizing allergic patients |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123319 Medthod of Treating a systemic inflammatory disorder and damaged internal tissues |
| 05/16/2013 | US20130122295 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 05/16/2013 | US20130122080 Pharmaceutical composition capable of immuno-regulation or enhancement of immune response |
| 05/16/2013 | US20130122076 Transdermal Patch Having Ultrasound Transducer for Administering Thrombolytic Reagents to Patients Having a Protein Misfolding Disease |
| 05/16/2013 | US20130122018 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 05/16/2013 | US20130122011 Multiple-variable dose regimen for treating TNFa-related disorders |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/15/2013 | EP2592094A1 Binding members for IgE molecules |
| 05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
| 05/15/2013 | EP2592075A1 Pyridazine compounds for the treatment of inflammatory diseases |
| 05/15/2013 | EP2591822A1 Treatment of diseases |
| 05/15/2013 | EP2591799A1 Cancer peptide vaccine |
| 05/15/2013 | EP2591797A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 05/15/2013 | EP2591790A1 T cell apoptosis inducer |
| 05/15/2013 | EP2591776A1 Use of kukoamine a and kukoamine b |
| 05/15/2013 | EP2590981A1 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 05/15/2013 | EP2590956A1 5-(biphenyl-4-yl)-3-phenyl-1,2,4-oxadiazolyl derivatives as ligands on the sphingosine 1-phosphate (s1p) receptors |
| 05/15/2013 | EP2590679A1 Immunomodulatory protein constructs with a helical polymeric backbone |
| 05/15/2013 | EP2590666A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
| 05/15/2013 | EP2590641A2 Methods of immune modulation |
| 05/15/2013 | EP2590639A1 Treatment of delayed cutaneous hypersensitivity conditions with s-farnesylthiosalicylic acid and analogs thereof |
| 05/15/2013 | EP2590520A2 Array of age-tailored nutritional formula with optimum fat content |
| 05/15/2013 | CN103108883A Novel allergen |
| 05/15/2013 | CN103108655A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 05/15/2013 | CN103108635A Liquid formulations of rupatadine fumarate |
| 05/15/2013 | CN103108630A Allergen deactivator composition, articles and methods |
| 05/15/2013 | CN103103148A Method for screening Bacillus subtilis applicable to taking corn starch sewage as carbon source of culture medium and production method of wettable powder |
| 05/15/2013 | CN103103092A Silkworm male moth mulberry wine as well as preparation method thereof |
| 05/15/2013 | CN103103090A Silkworm chrysalis cordyceps wine and preparation method thereof |
| 05/15/2013 | CN103103089A Silkworm chrysalis cordyceps bombyx wine and manufacturing method thereof |
| 05/15/2013 | CN103102383A Crystal form A of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103102382A Crystal form B of glycyrrhetinic acid-30-amide derivative and preparation method thereof |
| 05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103102283A Preparation method of chalcone oxime compound and application of the same as novel immunosuppressant |
| 05/15/2013 | CN103100089A Oral pH responsive intestinal targeting vector as well as preparation method and applications thereof |
| 05/15/2013 | CN103099955A Medicine pair preparation made from rhizoma polygonati and Chinese-date and having effect of cooperatively increasing non-specific immunity activity |
| 05/15/2013 | CN103099902A Traditional Chinese medicine composition for treating subacute thyroiditis and preparation method thereof |
| 05/15/2013 | CN103099888A Foot massage bag for eliminating fatigue, improving sleep and enhancing physical strength and preparation technology of foot massage bag |
| 05/15/2013 | CN103099883A Common cold tea |
| 05/15/2013 | CN103099845A Method for extracting perillaseed hydrophilic chemical component from perillaseed oil residue |
| 05/15/2013 | CN103099832A Method for biotransformation of pseudo-ginseng by using Candida |
| 05/15/2013 | CN103099826A Method for extracting taxusflavone from taxus chinensis leaves |
| 05/15/2013 | CN103099825A Novel cordyceps sinensis capsule and preparation method thereof |
| 05/15/2013 | CN103099824A Cordyceps sinensis ultra-fine powder buccal tablet |
| 05/15/2013 | CN103099822A Method for producing omphalia lapidescens schroet tables |
| 05/15/2013 | CN103099778A Exterior medicine composition of fluocinolone acetonide and ester of fluocinolone acetonide |
| 05/15/2013 | CN103099756A Acne-removing and anti-allergic cosmetic cream and preparation method thereof |
| 05/15/2013 | CN103099210A Polygonum multiflorum nutrient tablet and making method thereof |
| 05/15/2013 | CN103099204A Dried rehamnnia root health care composition and preparation technology thereof |
| 05/15/2013 | CN102626418B Application of pyrola polysaccharide in preparing immunity-enhancing medicaments and health food |
| 05/15/2013 | CN102357102B Preparation method of transfer factor soluble powder for animals |
| 05/15/2013 | CN102309727B Chinese patent medicine for facial beautification and longevity |
| 05/15/2013 | CN102302519B Propolis nano-emulsion and preparation method thereof |
| 05/15/2013 | CN102294010B Medicine with functions of strengthening body resistance and eliminating depression and its production method |
| 05/15/2013 | CN102209530B Orally administrable immunostimulant product for aquaculture |
| 05/15/2013 | CN101744841B Bifidobacterium for treating inflammatory disease |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/15/2013 | CN101627056B Y-type polyethylene glycol modified g-csf and preparation method and use thereof |
| 05/15/2013 | CN101627034B Amino- pyridine derivatives as s1p1 /edg1 receptor agonists |
| 05/15/2013 | CN101313061B Method of expanding double negative T cells |
| 05/15/2013 | CN101019853B Composition containing dihomo-gamma-linolenic acid (DGLA) as the active ingredient |
| 05/14/2013 | US8440696 Method of using diketopiperazines and composition containing them |
| 05/14/2013 | US8440668 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of type 2 diabetes |
| 05/14/2013 | US8440644 Compounds as receptor modulators with therapeutic utility |
| 05/14/2013 | US8440190 Antibody variants |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2694495C Capsule composition for use as immunogen against campylobacter jejuni |
| 05/14/2013 | CA2579353C Therapeutic strategy for treating autoimmune and degenerative diseases |
| 05/14/2013 | CA2549114C Immunostimulant composition comprising at least one toll-like 7 receptor or toll-like 8 receptor agonist and a toll-like 4 receptor agonist |
| 05/14/2013 | CA2548202C Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo |
| 05/14/2013 | CA2539193C New rarbeta receptor-activating ligand, method for the preparation ther eof and use thereof in human medicine and in cosmetics |
| 05/14/2013 | CA2532965C 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/14/2013 | CA2516624C 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 05/14/2013 | CA2506696C Method for the prevention of malaria |
| 05/14/2013 | CA2453937C Antigenic polypeptides |
| 05/14/2013 | CA2434303C Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 05/10/2013 | WO2013067302A1 Method of treatment |
| 05/10/2013 | WO2013067300A1 Method of treatment |